MAYO CLINIC
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
New Technique as an Additional Diagnostic Tool for Women Undergoing Neoadjuvant Therapy for Breast Cancer
- First Posted Date
- 2007-12-03
- Last Posted Date
- 2012-01-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT00566085
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
The Effect of Grape Seed Extract on Estrogen Levels of Postmenopausal Women
- First Posted Date
- 2007-12-03
- Last Posted Date
- 2012-01-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 39
- Registration Number
- NCT00566553
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
- Conditions
- Interventions
- First Posted Date
- 2007-11-29
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 35
- Registration Number
- NCT00564889
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2007-11-22
- Last Posted Date
- 2020-04-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 33
- Registration Number
- NCT00562328
- Locations
- 🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic Cancer Center, Rochester, Minnesota, United States
CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis
- Conditions
- Interventions
- First Posted Date
- 2007-11-15
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 378
- Registration Number
- NCT00558896
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
Testing Methylphenidate for Smoking Abstinence
- First Posted Date
- 2007-10-26
- Last Posted Date
- 2011-04-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 80
- Registration Number
- NCT00549640
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Trial of Montelukast in Eosinophilic Esophagitis
- Conditions
- Interventions
- First Posted Date
- 2007-08-03
- Last Posted Date
- 2015-11-03
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 41
- Registration Number
- NCT00511316
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy
- Conditions
- Interventions
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2017-02-01
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 34
- Registration Number
- NCT00498368
- Locations
- 🇺🇸
Stanford University, San Francisco, California, United States
🇺🇸Columbia University Medical Center, New York, New York, United States
🇺🇸University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States
X-3 Polyethylene Survival Outcomes Study
- Conditions
- Interventions
- First Posted Date
- 2007-06-28
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 518
- Registration Number
- NCT00493792
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
- Conditions
- Interventions
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2014-10-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 22
- Registration Number
- NCT00486421
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States